Literature DB >> 7576914

Direct interaction of complement factor H with the C1 domain of HIV type 1 glycoprotein 120.

C Pintér1, A G Siccardi, R Longhi, A Clivio.   

Abstract

A protein that binds specifically to Env 105-119 (HEDIISLWDQSLKPC) was found in pools of normal human plasma when this peptide was used in affinity chromatography procedures. These samples represented the negative control in experiments aimed at the purification of putative human antibodies to the Env 105-119 region from AIDS sera. In this article we describe the biochemical characterization of this protein, which turned out to be complement factor H (CFH). We propose a functional role for this protein in the complex, early steps of CD4-dependent HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576914     DOI: 10.1089/aid.1995.11.577

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

1.  Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics.

Authors:  Vivekananda Shetty; Pooja Jain; Zacharie Nickens; Gomathinayagam Sinnathamby; Anand Mehta; Ramila Philip
Journal:  OMICS       Date:  2011-10

Review 2.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

Review 3.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Human plasma enhances the infectivity of primary human immunodeficiency virus type 1 isolates in peripheral blood mononuclear cells and monocyte-derived macrophages.

Authors:  S C Wu; J L Spouge; S R Conley; W P Tsai; M J Merges; P L Nara
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.

Authors:  S Ram; A K Sharma; S D Simpson; S Gulati; D P McQuillen; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

Review 6.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

7.  Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae.

Authors:  S Ram; D P McQuillen; S Gulati; C Elkins; M K Pangburn; P A Rice
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

8.  Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

Authors:  H Stoiber; C Pintér; A G Siccardi; A Clivio; M P Dierich
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

9.  V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.

Authors:  Lautaro G Perez; David R Martinez; Allan C deCamp; Abraham Pinter; Phillip W Berman; Donald Francis; Faruk Sinangil; Carter Lee; Kelli Greene; Hongmei Gao; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Jerome H Kim; Peter Gilbert; David C Montefiori
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 10.  Complement Evasion Strategies of Viruses: An Overview.

Authors:  Palak Agrawal; Renuka Nawadkar; Hina Ojha; Jitendra Kumar; Arvind Sahu
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.